Lung cancer incidence in Bosnia and Hercegovina is high. The implementation of evidence-based lung cancer screening based on low-dose computed tomography (LDCT) may detect lung cancer early and decrease mortality specific to lung cancer. However, LDCT receipt may be unsatisfactory in Europe due to a low distribution of scanners and radiologists or poor access to care. In this paper, we propose a framework for the implementation of lung cancer screening in primary healthcare of Bosnia and Herzegovina based on the United States Preventative Services Task Force recommendation from 2021 and the American College of Radiology Lung CT Screening Reporting & Data System from 2022.
Moyer V. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;330–8.
2.
American College of Radiology. Lung CT Screening Reporting and Data System (Lung-RADS): Assessment Categories. 2022;
3.
Doubeni C, Wilkinson J, Korsen N, Midthun D. Lung cancer screening guidelines implementation in primary care: A Call to Action. Ann Fam Med. 2020;196–201.
4.
Brenner A, Malo T, Margolis M, Lafata E, James J, Vu S, et al. Evaluating shared decision making for lung cancer screening. JAMA Intern Med. 2018;1311–6.
5.
Haas J, Sprague B, Klabunde C, Tosteson A, Chen J, Bitton A, et al. PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) Consortium. Provider attitudes and screening practices following changes in breast and cervical cancer screening guidelines. J Gen Intern Med. 2016;52–9.
6.
Hamann H, Hoeve V, Carter-Harris E, Studts L, Ostroff J, J. Multilevel opportunities to address lung cancer stigma across the cancer control continuum. J Thorac Oncol. 2018;1062–75.
7.
Lei F, Lee E. Barriers to lung cancer screening with low-dose computed Tomography. Oncol Nurs Forum. 2019;60–71.
8.
Balata H, Evison M, Sharman A, Crosbie P, Booton R. CT screening for lung cancer: Are we ready to implement in Europe? Lung Cancer. 2019;25–33.
9.
Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel C, et al. European position statement on lung cancer screening. Lancet Oncol. 2017;754-e766.
10.
Us Preventive S, Task Force ;, Krist A, Davidson K, Mangione C, Barry M, et al. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;962–70.
11.
Jeon J, Holford T, Levy D, Feuer E, Cao P, Tam J, et al. Smoking and lung cancer mortality in the United States from 2015 to 2065: a comparative modeling approach. Ann Intern Med. 2018;684–93.
12.
Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019;1162–9.
13.
De Koning H, Van Der Aalst C, De Jong P, Scholten E, Nackaerts K, Heuvelmans M, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;503–13.
14.
Aberle D, Berg C, Black W, Church T, Fagerstrom R, Galen B, et al. The National Lung Screening Trial: overview and study design. Radiology. 2011;243–53.
15.
Ebell M, Bentivegna M, Hulme C. Cancer-specific mortality, all-cause mortality, and overdiagnosis in lung cancer screening trials: a meta-analysis. Ann Fam Med. 2020;545–52.
16.
Javna zdravstvena ustanova Institut za javno zdravstvo Republike Srpske (Public Health Institue of the Republic of Srpska). 13AD;
17.
Zavod za javno zdravstvo Federacije Bosne i Hercegovine (Institute for Public Health FB&H). 14AD;
18.
Lj M, Vukojević B, Pepić A, Preradović D, Gligorić D. Tobacco consumption in Bosnia and Herzegovina. 2019;
19.
Wipfli H, Samet J. One hundred years in the making: the global tobacco epidemic. Annu Rev Public Health. 2016;149–66.
20.
Siegel R, Miller K, Fuchs H, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;7–33.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
